Monoprost eye drops solution 50 mcg/ml. sachet №30

Description

Monoprost composition
The main active ingredient of the drug is latanoprost.
The auxiliary substances are: castor oil, sorbitol, carbomer, macrogol, disodium edetate, sodium hydroxide, water for injection.
1 ml of solution contains 0.05 mg of the main active ingredient – latanoprost.

Release form
It is produced in the form of eye drops, in dropper bottles with a volume of 2.5 ml.

Pharmacological properties
Monoprost belongs to a group of miotic drugs, prostaglandin analogs, which are used in the treatment of glaucoma.
The main mechanism of action of its main active ingredient latanoprost is the ability to increase uveoscleral outflow.
Has shown its effectiveness when used as a monopreparation. It is also active in combination with beta-blockers, in particular timolol.
Latanoprost does not affect the excretion of intraocular fluid by the body. Does not affect the blood-ophthalmic barrier.
Has no effect (or it is insignificant) on the blood circulation inside the eye. At the same time, when applied topically, conjunctivitis and episcleral hyperemia can be observed.

Indications
Monoprost is used to treat increased eye pressure.
Including, for:

• reduction of increased intraocular pressure in patients suffering from open-angle glaucoma and increased intraocular pressure;
• reduction of increased intraocular pressure in pediatric patients with increased intraocular pressure and childhood glaucoma.

Contraindications
Not applicable if the patient has hypersensitivity (allergy) to one of the components that make up the drug.

Children
It is not recommended to use in pediatrics.

Application during pregnancy and lactation
It is not used to treat pregnant women.
If there is a need to take this drug, then during treatment, lactation (breastfeeding) should be suspended.

Method of administration and dosage
1 drop of Monoprost is injected daily into the affected eye, 1 time per day.
The greatest effect is achieved if the drug is used in the evening, before going to bed.
More frequent use reduces the effectiveness of the drug (pressure does not decrease so actively), therefore, increasing the dosage is not recommended.
Missing a dose is not a reason for increasing the dosage or frequency of administration of the drug.
To increase the effectiveness of the effect, after instilling the drug, you need to slightly press down the eyelids, squeezing the lacrimal sac (inner corner of the eye).
Contact lenses are removed before instillation. Their installation is possible only after 15-20 minutes.
If there is a need to instill other eye drops, then the break between their use should be at least 5 minutes.
Children’s dosage and frequency of administration does not differ from that of an adult.
The duration of treatment is determined by the attending physician.

Overdose
An overdose of the drug can cause:

• eye irritation;
• conjunctivitis;
• conjunctival hyperemia.

Accidental swallowing of the drug in large quantities may cause:

• nausea;
• vomiting;
• abdominal pain;
• increased sweating;
• increased fatigue;
• bronchospasm;
• hot flashes.

In this case, treatment of symptoms, gastric lavage, and intake of enterosorbents is recommended.

Side effects
Therapy with this drug can cause side reactions in the form of:

• herpetic keratitis, keratitis, blepharitis;
• increased pigmentation of the iris;
• changes in eyelashes and vellus hair (increase in length, thickness, pigmentation and quantity);
• mild to moderate conjunctival hyperemia, eye irritation (burning with gritty sensation in the eyes, itching, dryness, tingling and foreign body sensation in the eye);
• point epithelial erosions, often asymptomatic;
• pain in the eyes;
• swelling of the eyelids;
• blurred vision, especially the first 15 minutes after the instillation procedure;
• conjunctivitis;
• iritis, uveitis;
• macular edema, symptomatic edema and corneal erosion;
• periorbital edema,
• the growth of eyelashes in the wrong direction, which can cause eye irritation, as well as the appearance of an additional row of eyelashes in the excretory ducts of the meibomian glands (distichiasis);
• photophobia;
• exacerbation of angina pectoris in patients with concomitant diseases;
• tachycardia;
• bronchial asthma, shortness of breath;
• rashes;
• myalgia, arthralgia;
• extremely rare – corneal calcification due to the intake of eye drops containing phosphate, in some patients who have significantly damaged the cornea.

Storage conditions and periods
The shelf life of the drug is no more than 2 years from the production date indicated on the package.
Store in a dry place out of the reach of children at a temperature not lower than 25 ° C.
Opened packaging should be used within 7 days.